Research Article
Impact of Polypharmacy on the Rehabilitation Outcome of Japanese Stroke Patients in the Convalescent Rehabilitation Ward
Table 3
Comparison of laboratory data.
| | Characteristic | All patients
() | Polypharmacy group
() | Nonpolypharmacy group
() | value |
| | Alb (g/dL) | 3.8 ± 0.5 | 3.7 ± 0.5 | 3.8 ± 0.4 | 0.6261 | | Scr (mg/dL) | 0.7 ± 0.3 | 0.7 ± 0.2 | 0.7 ± 0.3 | 0.8645 | | Ccr (mL/min) | 52.0 ± 17.7 | 51.2 ± 19.6 | 52.4 ± 16.7 | 0.7503 | | eGFR (mL/min/1.73 m2) | 78.3 ± 31.5 | 75.2 ± 29.2 | 80.4 ± 32.5 | 0.2622 | | HbA1c (NGSP) (%) | 6.1 ± 1.1 | 6.3 ± 1.2 | 5.9 ± 0.9 | 0.0923 | | FPG (mg/dL) | 124.8 ± 38.9 | 134.7 ± 39.0 | 119.8 ± 38.1 | 0.0295 | | T-Cho (mg/dL) | 175.6 ± 35.0 | 173.1 ± 39.5 | 177.0 ± 3.3 | 0.5463 | | TLC (×103/μL) | 1.5 ± 0.6 | 1.5 ± 0.5 | 1.5 ± 0.6 | 0.9251 | | WBC (×103/μm) | 6.3 ± 1.9 | 6.3 ± 1.7 | 6.4 ± 1.9 | 0.8085 |
|
|
Mean ± SD.
|
